We are constantly working to improve the site, and to add more laws to our database. If you are receiving value from using our site please consider signing up for a subscription to support the site and to get many additional benefits for you.
Key Benefits:
(You can close this ad by clicking anywhere on the page.)
Key Benefits:
Warned errors in the Resolution of 28 December 2011, of the Directorate General of Pharmacy and Health Products, published in the "Official Gazette of the State", number 314, of 30 December 2011, for which they are determined new sets of medicinal products to be dispensed in pharmacy offices through official medical prescription or dispensing order, their reference prices, and the reference prices set by Order SPI/30 52/2010 of 26 November 2010 are revised, and without the material content of the same being altered, it is necessary to make the necessary corrections:
On page 145956, where it says:
|
Annex | Active Principle | Administration path |
National Code | Filename | PVPIVa reference |
|---|---|---|---|---|---|
| C17 | Azithromycin. | ORAL. | 650821 | AZITHROMYCIN SANDOZ 200 mg/5 ml powder for oral suspension, 1 X 30 ml. | 4.72 |
| C17 | Azithromycin. | ORAL. | 651241 | Azithromycin Bexal 200mg/5ml powder for oral suspension in bottle, 1 bottle of 30ml. |
4.72 |
| C17 | Azithromycin. | ORAL. |
651282 | Azithromycin Bexal 200mg/5ml powder for oral suspension in bottle, 1 bottle of 15ml. | 3.12 |
| C17 | Azithromycin. |
ORAL. | 653122 | ARATRO 200 mg/5 ml powder for oral suspension in bottle, 1 bottle of 30ml. | 4.72 " |
You must say:
|
Annex | Active Principle | Administration path |
National Code | Filename | PVPIVa reference |
|---|---|---|---|---|---|
| C18 | Azithromycin. | ORAL PEDIATRIC. | 650821 | AZITHROMYCIN SANDOZ 200 mg/5 ml powder for oral suspension, 1 X 30 ml. | 6.06 |
|
C18 | Azithromycin. | PEDIATRIC ORAL. | 651241 | Azithromycin Bexal 200mg/5ml powder for oral suspension in bottle, 1 bottle of 30ml. | 6.06 |
| C18 | Azithromycin. | PEDIATRIC. | 651282 | Azithromycin Bexal 200mg/5ml powder for oral suspension in bottle, 1 bottle of 15ml. |
3.12 |
| C18 |
PEDIATRIC oral body. |
653122 | ARATRO 200 mg/5 ml powder for oral suspension in bottle, 1 bottle of 30ml. | 6.06 |
On page 145957, where it says:
|
Annex | Active Principle | Administration path |
National Code | Filename | PVPIVa reference | |
|---|---|---|---|---|---|---|
| C17 | Azithromycin. | ORAL. | 665041 | Azitrozina LEK 200 mg/5 ml powder for suspension. | 3.12 | |
| C17 | Azithromycin. | ORAL. | 665142 | Azitrozina LEK 200 mg/5 ml powder for suspension. | 4.72 |
|
| C17 | Azithromycin. | ORAL. | 665211 |
AZITHROMYCIN SALUTAS 200 mg/5 ml powder for oral suspension, 15 ml. | 3.12 | |
| C17 |
ORAL. | ORAL. | Centro_table_body"> 665212 | AZITHROMYCIN SALUTES 200 mg/5 ml powder for oral suspension, 30 ml. | 4.72 | |
| C17 | Azithromycin. | ORAL. | 672348 | AZITHROMYCIN MYLAN 200 mg/5 ml powder for oral suspension, 15 ml. | 3.12 | |
| C17 | Azithromycin. | ORAL. | Centro_table_body"> 672349 | AZITHROMYCIN MYLAN 200 mg/5 ml powder for oral suspension, 30 ml. | 4.72 " |
You must say:
|
Annex | Active Principle | Administration path |
National Code | Filename | PVPIVa reference | |
|---|---|---|---|---|---|---|
| C18 | Azithromycin. | ORAL PEDIATRIC. | 665041 | Azitrozina LEK 200 mg/5 ml powder for suspension. | 3.12 | |
| C18 | Azithromycin. | PEDIATRIC ORAL. | 665142 |
Azithromzine LEK 200 mg/5 ml powder for suspension. | 6.06 | |
| C18 | Azithromycin. | PEDIATRIC ORAL |
665211 | AZITHROMYCIN SALUTAS 200 mg/5 ml powder for oral suspension, 15 ml. | 3.12 | |
| C18 | Azithromycin. | PEDIATRIC. | 665212 | AZITHROMYCIN SALUTAS 200 mg/5 ml powder for oral suspension, 30 ml. | 6.06 | |
| C18 | Azithromycin. | PEDIATRIC ORAL | Centro_table_body"> 672348 | AZITHROMYCIN MYLAN 200 mg/5 ml oral suspension powder, 15 ml. | 3.12 | |
| C18 | Azithromycin. | PEDIATRIC. | 672349 | AZITHROMYCIN MYLAN 200 mg/5 ml powder for oral suspension, 30 ml. | 6.06 " |
On page 146069, where it says:
|
Set | Active Principle | Administration path |
National Code | Filename | PVPIVa reference |
|---|---|---|---|---|---|
|
C158 | Octreotide. | 660354 | 660354 | OCTREOTIDA GP PHARM 200 micrograms/ml Solution for injection, 1 vial. |
C158 |
| C158 | PARENTERAL. | PARENTERAL. | Centro_table_body"> 772129 | SANDOSTATIN 200 micrograms/ml solution injection, 1. | 4.34 " |
You must say:
|
Annex | Active Principle | Administration path |
National Code | Filename | PVPIVa reference |
|---|---|---|---|---|---|
| C158 | Octreotide. | 660354 | 660354 | OCTREOTIDA GP PHARM 200 micrograms/ml Solution for injection, 1 vial. |
C158 | C158 | PARENTERAL. | PARENTERAL. |
| Centro_table_body"> 772129 | SANDOSTATIN 200 micrograms/ml solution injection, 1. | 21.72 " |
Madrid January 27, 2012. -Director General of the Basic Portfolio of Services of the National System of Health and Pharmacy, Maria del Sagrario Pérez Castellanos.
